{
  "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9",
  "docSlug": "ed8052d583ef5c8745075e02dbad124b",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 31,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide outlines the status of THIO-101, 102, and 103, highlighting FDA designations and clinical trial progress.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/3",
  "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9",
  "deckJsonHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9.json",
  "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.872,
        "w": 0.238,
        "x": 0.762,
        "y": 0.128
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9de7919-6f3b-45e3-be20-67c93f9ed9f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.8,
        "w": 0.75,
        "x": 0.02,
        "y": 0.14
      },
      "kind": "list",
      "text": "Telomere-Targeting Agents for Cancer Therapy: THIO in clinic, Advancing pipeline; Efficacy; Safety; U.S. FDA: 3 Orphan Drug Designations; REGN: Clinical Supply Agreement; Phase 2 Go-to-Market Accelerated Approval THIO-101 in NSCLC underway; Phase 2 Go-to-Market Accelerated Approval THIO-102 planned to start; Phase 2/3 Confirmatory/Expansion THIO-103 basket trial planned to start",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e432380d-b535-4a9a-8482-9975190e1a39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.48,
        "x": 0.02,
        "y": 0.02
      },
      "kind": "title",
      "text": "INVESTMENT OVERVIEW",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d6c4c91-61ea-4cf3-be6b-c2e72d7692f0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "56f337dd-faf1-478a-9e78-d7da1ee3ec6f",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "The Ask",
      "beatSlug": "sequoia-pitch-the-ask",
      "evidence": "The 'executive_summary' slide provides an investment overview",
      "position": 5,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}